-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2015 to Q2 2025.
- ELITE PHARMACEUTICALS INC /NV/ Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 30 Jun 2025 was $158,926, a 28.7% decline year-over-year.
- ELITE PHARMACEUTICALS INC /NV/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $672,409, a 463% increase from 2023.
- ELITE PHARMACEUTICALS INC /NV/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $119,412, a 89.1% decline from 2022.
- ELITE PHARMACEUTICALS INC /NV/ annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $1,098,537, a 518% increase from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)